Home/Filings/4/0001171843-18-002393
4//SEC Filing

Harrelson Lori R. 4

Accession 0001171843-18-002393

CIK 0001105533other

Filed

Mar 29, 8:00 PM ET

Accepted

Mar 30, 5:14 PM ET

Size

4.9 KB

Accession

0001171843-18-002393

Insider Transaction Report

Form 4
Period: 2018-03-28
Harrelson Lori R.
Vice President of Finance
Transactions
  • Award

    Common Stock

    2018-03-28+22,62934,405 total
Footnotes (1)
  • [F1]The shares are subject to a lapsing right of repurchase by the issuer, which shall lapse as to 11,315 shares on June 15, 2018, and with respect to the remaining 11,314 shares on December 14, 2018, subject to the Reporting Person continuing to be an employee of the issuer through each such date.

Issuer

ARGOS THERAPEUTICS INC

CIK 0001105533

Entity typeother

Related Parties

1
  • filerCIK 0001543053

Filing Metadata

Form type
4
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 5:14 PM ET
Size
4.9 KB